Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NuGen Medical Devices Inc V.NGMD

Alternate Symbol(s):  NGMDF

NuGen Medical Devices Inc. is a Canada-based specialty medical device company. The Company is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. It is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. It is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The Company's InsuJet technology platform is based on jet-stream administration of liquid drugs. The Company manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.


TSXV:NGMD - Post by User

Post by lscfaon Jan 21, 2024 7:06pm
246 Views
Post# 35838260

More transparency required

More transparency required

Mgmt should breakout revenues into devices sold and consumables. This would make clear the trend in growing recurring revenue and the lumpiness of device sales. My guess at break down....


 

 

 

Devices o/s

Qtr ending

Device rev 

Resupply rev

Revenue

Gross profit

 

 

2,905

Jun 24 (e)

0

156,893

156,893

112,963

72.0%

1500 to Mexico

1,611

Mar 24 (e)

220,000

87,000

307,000

221,040

72.0%

500 to Romania

1,411

Dec 23 (e) 

82,000

76,181

158,181

113,890

72.0%

500 to Mexico

759

Sep 23

74,856

40,963

115,819

73,315

63.3%

 

418

Jun 23

0

22,549

22,549

12,680

56.2%

 

451

Mar 23

0

24,376

24,376

17,181

70.5%

 

<< Previous
Bullboard Posts
Next >>